Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience

Annals of Oncology

Volumn 7, Issue 7, 1996, Pages 719-724

  Pavlovsky, S ^a,b   Koziner, B ^a   Milone, G ^a   Lastiri, F ^a   Bayo, R ^a   Fernandez I ^a   Dengra, C ^a   Martinez Rolon J ^a   Feldman, L ^a   Kusminsky, G ^a   Corrado, C ^a   Bullorsky, E ^a   Milone, J ^a   Garcia, J J ^a   Cerutti, I ^a   Saporito, G ^a   Robinson, A ^a   Canepa, C ^a  

^a GATMO   (Argentina)

^b Fundacion para Combatir La Leucemia   (Argentina)

Author keywords

Autograft; Bone marrow; Hematological recovery; Peripheral blood; Progenitor cells; Prognostic factors

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOGRAFT; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CHILD; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029814432     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010721     Document Type: Article

References (16)

1. Bishop MR, Anderson JR, Jackson JD et al. High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994; 83: 610-6.
2. Nademanee A, Sniecinski I, Schmidt GM et al. High dose therapy followed by autologous peripheral-blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 1994; 12(10): 2176-86.
3. Lobo F, Kessinger A, Landmark JD et al. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. Bone Marrow Transplant 1991; 3: 389-92.
4. Rabinowe SN, Neuberg D, Bierman PJ et al. Long-term follow-up of a phase III study of recombinant human granulocytemacrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies. Blood 1993; 81: 1903-8.
5. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 1994; 343, 8899: 696-700.
6. Schwartzberg L, Birch R, Blanco R et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993; 11: 369-74.
7. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-5.
8. Sheridan WP, Begley CG, Lo LB et al. Phase II study of autologous filgrastrim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994; 14: 105-11.
9. Henon R, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood styem cell transplants. Bone Marrow Transplant 1992; 9: 285-91.
10. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplant and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-84.
11. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-5.
12. Haas R, Hohaus S, Egerer G et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992; 9: 459-65.
13. Bender JG, Lum L, Unverzagt KL et al. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-85.
14. Brice P, Divine M, Marolleau JP et al. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994; 14: 51-5.
15. Lopez M, Mortel O, Pouillart P et al. Acceleration of hemopoietic recovery after bone marrow transplantation by low doses of peripheral blood stem cells. Bone Marrow Transplant 1991; 7: 173-81.
16. Haas R, Mohle R, Fruhauf S et al. Patients characteristics associated with succesful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 12: 3787-94.